The Firm Alonso Krangle LLP Files Fosamax Lawsuit on Behalf of a Woman who Allegedly Suffered a Femur Fracture as a Result of Her Use of Fosamax

Share Article

Attorneys Andres Alonso and David Krangle Announce that Alonso Krangle LLP has Filed Suit on Behalf of a Wisconsin Woman who was Diagnosed with a Right Femur Fracture after Using the Bisphosphonate, Fosamax, for over Five Years

Alonso Krangle LLP - Fighting for victims of personal injury, defective drug and medical device litigation, construction accidents, nursing home abuse, medical malpractice, Whistleblower, & Employee Rights

Alonso Krangle LLP - Fighting for victims of personal injury, defective drug and medical device litigation, construction accidents, nursing home abuse, medical malpractice, Whistleblower, & Employee Rights

The lawyers at the firm Alonso Krangle LLP are currently offering free Fosamax lawsuit evaluations to anyone who experienced a femur fracture that may be due to Fosamax side effects.

The law firm Alonso Krangle LLP, a national law firm focused on fighting for the rights of victims due to drug side effects, announce their firm has filed a Fosamax lawsuit on behalf of Judy Kinning, a resident of Wisconsin, who was diagnosed with a right femur fracture after using the oral bisphosphonate, Fosamax, for over five years. Ms. Kinning’s Fosamax lawsuit was filed on January 30, 2012, in the Superior Court of New Jersey, Atlantic County Division, and names Merck Sharp & Dohme Corp. f/k/a Merck & Company, Inc. and Teva Pharmaceuticals as Defendants (Docket No. ATL-L-000795-2012-MT)

The lawyers at the firm Alonso Krangle LLP are currently offering free Fosamax lawsuit evaluations to anyone who experienced a femur fracture that may be due to Fosamax side effects. To discuss a potential Fosamax lawsuit claim with an experienced and compassionate Fosamax side effects lawyer, please contact Alonso Krangle LLP at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

According to Ms. Kinning’s lawsuit, she was first prescribed Fosamax on or before July 1, 2004, and used the medication as prescribed, and in a foreseeable manner through 2010. On or about February 13, 2010, Ms. Kinning was diagnosed with a right femur fracture. Her lawsuit alleges that Ms. Kinning’s long-term use of Fosamax for over five years caused her to be permanently and severely injured. As a result, she requires and will require future and ongoing medical care. The complaint further alleges that Ms. Kinning would not have used Fosamax had the Defendants properly disclosed the risks or side effects associated with its long-term use.

According to Ms. Kinning’s Fosamax lawsuit, over the past few years, there have been an increasing number of reports of patients suffering stress factures as a result of severely suppressed bone turnover as a result of long-term Fosamax use. The complaint further alleges that the Defendants knew of the significant risk of severely suppressed bone turnover, brittle bones, and multiple stress fractures associated with long-term use of Fosamax, but did not sufficiently warn consumers, the Plaintiff, her doctors or the medical community

The complaint charges the Defendants with negligence; breach of implied and express warranties; three counts of strict liability; fraudulent concealment; negligent misrepresentation; unfair and deceptive trade practices; three counts of violating the New Jersey Products Liability Act, including defective design, manufacturing defect, and failure to warn; and violation of the Wisconsin Deceptive Trade Practices Act. The lawsuit seeks, among other things, actual damages in an amount to be determined at trial, and punitive damages under Common Law, the New Jersey Products Liability Act and the New Jersey Punitive Damages Act.

What is Fosamax?
Fosamax, known generically as alendronate, is an oral bisphosphonate that limits bone loss by inhibiting the breakdown of old or damaged bones. In 1995, the U.S. Food and Drug Administration (FDA) approved the use of Fosamax, and since then it has been used to treat osteoporosis, osteopenia, Paget’s Disease and other conditions. In October 2010, the [fda.gov/drugs/drugsafety/ucm229009.htm] FDA ordered the makers of Fosamax and other bisphosphonates to add information about the risk of atypical femur fractures to the “Warnings and Precautions” section of their labels. The FDA ordered the label change after a study involving over 300 women who sustained such fractures found that 94 percent had taken a bisphosphonate. Most had been on the drugs for five years or more.

Alonso Krangle LLP offers free lawsuit evaluations to any Fosamax user who suffered a femur fracture that could be associated with long-term use of this drug. To discuss a potential claim with one of the experienced and compassionate Fosamax femur fracture lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.

For more information about Alonso Krangle LLP or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact:
Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York 11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Krangle

Andres Alonso
Visit website